article · Results in Chemistry
A novel, highly sensitive, and cost-effective biosensor for prostate-specific antigen (PSA) detection has been developed using bioengineered nanotechnology. This biosensor integrates a Fe(III)-Gallic acid metal organic framework (Fe-GA MOF) embedded in a carboxymethyl cellulose polymer thin film, coupled with a PSA monoclonal antibody for capture. The resulting sensor demonstrates exceptional performance in detecting PSA levels within a wide concentration range (0.1–170 ng/mL), with a remarkable limit of detection of 0.06 ng/mL. This advanced technology surpasses conventional methods by providing enhanced sensitivity, stability, and reduced interference. The biosensor holds immense potential for early prostate cancer diagnosis, monitoring treatment response, and detecting recurrence. Moreover, its applicability may extend to other cancers characterized by elevated PSA levels, ultimately improving patient outcomes through timely intervention and optimized care.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1016/j.rechem.2024.101738
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.